Search Results

NSC 23766 50mg 50mg  | Purity Not Available

Adooq Bioscience

NSC 23766 is a selective inhibitor of Rac1-GEF interaction. Prevents Rac1 activation by Rac-specific guanine nucleotide exchange factors (GEFs) TrioN and Tiam1 (IC50 ~ 50 ??M) without affecting Cdc42 or RhoA activation.

More Information Supplier Page

NSC 23766 25mg 25mg  | Purity Not Available

Adooq Bioscience

NSC 23766 is a selective inhibitor of Rac1-GEF interaction. Prevents Rac1 activation by Rac-specific guanine nucleotide exchange factors (GEFs) TrioN and Tiam1 (IC50 ~ 50 ??M) without affecting Cdc42 or RhoA activation.

More Information Supplier Page

NSC 23766 100mg 100mg  | Purity Not Available

Adooq Bioscience

NSC 23766 is a selective inhibitor of Rac1-GEF interaction. Prevents Rac1 activation by Rac-specific guanine nucleotide exchange factors (GEFs) TrioN and Tiam1 (IC50 ~ 50 ??M) without affecting Cdc42 or RhoA activation.

More Information Supplier Page

Inauhzin 50mg 50mg  | Purity Not Available

Adooq Bioscience

Inauhzin is a potent SIRT inhibitor, which effectively reactivates p53 by inhibiting SIRT1 activity, promotes p53-dependent apoptosis of human cancer cells without causing apparently genotoxic stress.

More Information Supplier Page

Inauhzin 5mg 5mg  | Purity Not Available

Adooq Bioscience

Inauhzin is a potent SIRT inhibitor, which effectively reactivates p53 by inhibiting SIRT1 activity, promotes p53-dependent apoptosis of human cancer cells without causing apparently genotoxic stress.

More Information Supplier Page

Inauhzin 25mg 25mg  | Purity Not Available

Adooq Bioscience

Inauhzin is a potent SIRT inhibitor, which effectively reactivates p53 by inhibiting SIRT1 activity, promotes p53-dependent apoptosis of human cancer cells without causing apparently genotoxic stress.

More Information Supplier Page

Inauhzin 10mg 10mg  | Purity Not Available

Adooq Bioscience

Inauhzin is a potent SIRT inhibitor, which effectively reactivates p53 by inhibiting SIRT1 activity, promotes p53-dependent apoptosis of human cancer cells without causing apparently genotoxic stress.

More Information Supplier Page

Losmapimod 50mg 50mg  | Purity Not Available

Adooq Bioscience

Losmapimod, also know as GW856553 or GW856553X, is a drug developed by GlaxoSmithKline which acts as a selective inhibitor of the enzyme family known as p38 mitogen-activated protein kinases.

More Information Supplier Page

Losmapimod 25mg 25mg  | Purity Not Available

Adooq Bioscience

Losmapimod, also know as GW856553 or GW856553X, is a drug developed by GlaxoSmithKline which acts as a selective inhibitor of the enzyme family known as p38 mitogen-activated protein kinases.

More Information Supplier Page